Wintrust Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $691K | Sell |
3,891
-628
| -14% | -$115K | 0.61% | 32 |
|
|
2024
Q3 | $892K | Sell |
4,519
-39,207
| -90% | -$7.32M | 0.66% | 28 |
|
|
2024
Q2 | $7.5M | Buy |
43,726
+937
| +2% | +$155K | 0.61% | 31 |
|
|
2024
Q1 | $7.79M | Buy |
42,789
+19
| +0% | +$3.27K | 0.69% | 28 |
|
|
2023
Q4 | $6.63M | Buy |
42,770
+2,706
| +7% | +$395K | 0.64% | 29 |
|
|
2023
Q3 | $5.97M | Buy |
40,064
+2,924
| +8% | +$429K | 0.63% | 34 |
|
|
2023
Q2 | $5M | Buy |
37,140
+10,493
| +39% | +$1.54M | 0.5% | 40 |
|
|
2023
Q1 | $4.25M | Buy |
26,647
+831
| +3% | +$127K | 0.54% | 36 |
|
|
2022
Q4 | $4.17M | Sell |
25,816
-251
| -1% | -$38.5K | 0.55% | 37 |
|
|
2022
Q3 | $3.5M | Buy |
26,067
+431
| +2% | +$61.8K | 0.44% | 45 |
|
|
2022
Q2 | $3.93M | Buy |
25,636
+1,421
| +6% | +$217K | 0.47% | 42 |
|
|
2022
Q1 | $3.93M | Sell |
24,215
-873
| -3% | -$127K | 0.38% | 46 |
|
|
2021
Q4 | $3.4M | Sell |
25,088
-585
| -2% | -$69.1K | 0.32% | 50 |
|
|
2021
Q3 | $2.77M | Sell |
25,673
-440
| -2% | -$50.3K | 0.37% | 52 |
|
|
2021
Q2 | $2.94M | Buy |
26,113
+339
| +1% | +$38.2K | 0.3% | 62 |
|
|
2021
Q1 | $2.79M | Sell |
25,774
-127
| -0.5% | -$13.6K | 0.29% | 70 |
|
|
2020
Q4 | $2.77M | Buy |
25,901
+563
| +2% | +$54.1K | 0.79% | 31 |
|
|
2020
Q3 | $2.22M | Buy |
25,338
+999
| +4% | +$94.1K | 0.3% | 70 |
|
|
2020
Q2 | $2.39M | Buy |
24,339
+1,543
| +7% | +$136K | 0.33% | 58 |
|
|
2020
Q1 | $1.74M | Buy |
22,796
+975
| +4% | +$83K | 0.29% | 67 |
|
|
2019
Q4 | $1.93M | Sell |
21,821
-754
| -3% | -$62.6K | 0.27% | 73 |
|
|
2019
Q3 | $1.75M | Sell |
22,575
-11,109
| -33% | -$762K | 0.26% | 71 |
|
|
2019
Q2 | $2.78M | Sell |
33,684
-4,717
| -12% | -$371K | 0.42% | 49 |
|
|
2019
Q1 | $3.46M | Buy |
38,401
+18,131
| +89% | +$1.48M | 0.56% | 34 |
|
|
2018
Q4 | $1.96M | Buy |
20,270
+6,989
| +53% | +$615K | 0.37% | 56 |
|
|
2018
Q3 | $1.26M | Sell |
13,281
-2,371
| -15% | -$225K | 0.2% | 97 |
|
|
2018
Q2 | $1.45M | Buy |
15,652
+2,217
| +17% | +$217K | 0.25% | 86 |
|
|
2018
Q1 | $1.27M | Sell |
13,435
-15,147
| -53% | -$1.66M | 0.32% | 62 |
|
|
2017
Q4 | $2.76M | Buy |
28,582
+382
| +1% | +$36K | 0.65% | 28 |
|
|
2017
Q3 | $2.51M | Sell |
28,200
-1,328
| -4% | -$101K | 0.63% | 27 |
|
|
2017
Q2 | $2.14M | Buy |
29,528
+235
| +0.8% | +$15.8K | 0.57% | 34 |
|
|
2017
Q1 | $1.91M | Buy |
29,293
+18,544
| +173% | +$1.17M | 0.54% | 30 |
|
|
2016
Q4 | $673K | Buy |
10,749
+1,597
| +17% | +$97.5K | 0.28% | 71 |
|
|
2016
Q3 | $577K | Sell |
9,152
-3,825
| -29% | -$248K | 0.27% | 76 |
|
|
2016
Q2 | $3K | Buy |
+12,977
| New | +$791K | 0.01% | 176 |
|
Other funds holding ABBV
Wintrust Investments's ABBV Position: Q4 2024 in Review
Wintrust Investments reduced its AbbVie (ABBV) stake by 14% in Q4 2024, selling an estimated $115K and leaving 3,891 shares worth $691K. The position accounts for 0.61% of the portfolio, ranked #32.
Wintrust Investments first reported a position in ABBV in Q2 2016 and has held it in 35 quarters since. The position peaked at $7.79M in Q1 2024. 3,745 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.
- Wintrust Investments held 3,891 shares of AbbVie worth $691K as of Q4 2024.
- Wintrust Investments sold 628 AbbVie shares in Q4 2024, an estimated $115K.
- AbbVie made up 0.61% of Wintrust Investments's portfolio in Q4 2024, its #32 holding.
- Wintrust Investments first reported a position in AbbVie in Q2 2016 and has held it in 35 quarters since.
- Wintrust Investments's AbbVie position peaked at $7.79M in Q1 2024.
- 3,745 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.
Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.